Dados B3 › VIVT3 × TIMS3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | VIVT3 | TIMS3 | year |
|---|---|---|---|
| ROE | 8.0% | 0.0%! | 2024 |
| ROIC | 8.5% | 0.0%! | 2024 |
| ROA | 4.5% | 0.0%! | 2024 |
| Gross margin | 43.5% | 51.8% | 2023 |
| EBIT margin | 15.2% | 19.8% | 2023 |
| Net margin | 9.7% | 11.9% | 2023 |
| Net debt/EBITDA | 0.67x | -0.11x | 2023 |
| Current ratio | 0.96x | 0.89x | 2023 |
| Revenue growth (1y) | 7.2% | -100.0%! | 2024 |
| Revenue growth (5y CAGR) | 3.7% | 47.9%! | 2023 |
| Piotroski F-Score | 7/9 | 1/9! | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | VIVT3 | TIMS3 | year |
|---|---|---|---|
| P/E | 21.78x | — | 2025 × 2023 |
| P/B | 1.95x | 1.69x | 2025 × 2023 |
| EV/EBITDA | 5.95x | 3.60x | 2025 × 2023 |
| FCF yield | 8.4% | 18.0% | 2025 × 2023 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:11 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it